FDA approves ZITUVIMET by Zydus Lifesciences for Type 2 diabetes treatment

Zydus Lifesciences Limited has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for ZITUVIMET, a combination of Sitagliptin and ... Read More